1. Home
  2. CYTK vs EDU Comparison

CYTK vs EDU Comparison

Compare CYTK & EDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.34

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo New Oriental Education & Technology Group Inc.

EDU

New Oriental Education & Technology Group Inc.

HOLD

Current Price

$60.39

Market Cap

9.0B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
EDU
Founded
1997
1993
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
9.0B
IPO Year
2004
2006

Fundamental Metrics

Financial Performance
Metric
CYTK
EDU
Price
$63.34
$60.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
4
Target Price
$84.81
$62.80
AVG Volume (30 Days)
1.8M
1.0M
Earning Date
02-26-2026
01-28-2026
Dividend Yield
N/A
1.99%
EPS Growth
N/A
3.94
EPS
N/A
2.38
Revenue
$87,211,000.00
$5,140,631,000.00
Revenue This Year
$341.94
$10.91
Revenue Next Year
$75.44
$10.38
P/E Ratio
N/A
$25.33
Revenue Growth
2609.26
6.70
52 Week Low
$29.31
$40.66
52 Week High
$70.98
$63.78

Technical Indicators

Market Signals
Indicator
CYTK
EDU
Relative Strength Index (RSI) 49.19 63.87
Support Level $62.13 $55.04
Resistance Level $65.88 $63.78
Average True Range (ATR) 2.59 1.86
MACD 0.07 0.30
Stochastic Oscillator 54.84 66.53

Price Performance

Historical Comparison
CYTK
EDU

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About EDU New Oriental Education & Technology Group Inc.

New Oriental Education & Technology is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation and consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.

Share on Social Networks: